Home›Companies›Healthcare›Omeza Holdings

Omeza Holdings, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 10, 2025·Suggest an edit

About Omeza Holdings

Omeza Holdings is a private company based in Sarasota, Florida, incorporated in 2022 in Delaware. It has reported $13,806,280 raised in four offerings on Form D since March 2022. Its chief executive is Cynthia Flowers.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 19, 2024Jan 10, 2025$906,280of $2.4M target14$64,734EquityRule 506(c)Form D ↗
Jun 16, 2023Sep 14, 2023$6,500,000of $10.0M target39$166KEquityRule 506(b)Form D ↗
Nov 30, 2022Sep 14, 2023$1,600,000fully sold12$133KDebtRule 506(b)Form D ↗
Feb 11, 2022Mar 17, 2022$4,800,000of $5.0M target27$177KDebtRule 506(b)Form D ↗
Total, four offerings$13,806,280

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Omeza Holdings's Form D filed Jan 10, 2025.

AL
Ag Lafley
Director
CF
Cynthia Flowers
Chief Executive Officer and director
Richard Hague
Richard Hague
Director
Also a board member at Remedium Bio.
FM

Earlier filings also listed Robert Essner (director, last listed Sep 2023), Joel Morganroth (director, last listed Sep 2023), Thomas Gardner (executive officer and director, last listed Mar 2022) and Ronald Gelbman (director, last listed Mar 2022).

Sources

  1. SECOmeza Holdings, Inc. filing history